{
  "id": 2113237,
  "title": "Lupin Unit Signs €75 Million YUVEZZI Licensing Deal, Expands Eye-Care Business Across Europe",
  "url": "https://urgent.news/2026/08/20/lupin-unit-signs-75-million-yuvezzi-licensing-deal-expands-eye-care",
  "topic": "world",
  "section": "World",
  "published": "2026-08-20T10:09:26.000Z",
  "source": {
    "name": "Free Press Journal",
    "slug": "free-press-journal",
    "url": "https://www.freepressjournal.in/business/lupin-unit-signs-75-million-yuvezzi-licensing-deal-expands-eye-care-business-across-europe"
  },
  "original_language": "en",
  "account": null,
  "summary": "Mumbai: Lupin's subsidiary VISUfarma has signed an exclusive licensing agreement with US-based Visus Therapeutics to commercialise the eye treatment YUVEZZI across European markets. The agreement covers the European Union, United Kingdom, Switzerland, Norway and Iceland. VISUfarma will handle regulatory work, marketing, promotion, distribution and sales in these territories. Deal worth up to €75…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}